The potency, pharmacokinetic profile, and SC bioavailability of ARC15105 support its clinical investigation for chronic inhibition of von Willeband factor -mediated platelet activation.
Arteriosclerosis, thrombosis, and vascular biology
Department of Cardiology, Medical University of Vienna, Austria.
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):902-9
© Galenicom 1999-2013